• Privacy Policy
  • Terms and Conditions

© 2026 Sciad

  • Our Expertise
    • Design
      • Ads & Social Graphics
      • Branding
      • Marketing Assets
      • Video & Animation
      • Website Design & Development
    • Digital Marketing
      • Conversion Rate Optimisation
      • Digital Analytics & Reporting
      • Digital Marketing Strategy
      • Digital Press Office
      • Email Marketing
      • Lead Generation
      • PPC Marketing
      • SEO Services
      • Social Media Marketing
    • PR & Communications
      • Brand Positioning & Key Messaging
      • Communications Strategy
      • Conferences & Event Support
      • Media Relations
      • Reputation Management
      • Thought Leadership
  • Sectors
    • Digital Health
    • Engineering
    • Healthcare, Diagnostics & Medical Devices
    • Laboratory Instruments & Suppliers
    • Life Science & Biotech
    • Pharmaceuticals & Medicine
    • Science
    • Science & Healthcare Charities
    • Science Publishing & Academic Collaboration
    • Synthetic Biology
    • Med Tech
  • Our Work
  • News
  • About Us
    • Our Team
    • Careers
  • Contact Us
  • Royal Society of Chemistry and Cogent offer £400,000 Talent Recruitment Grant Funding

    Royal Society of Chemistry and Cogent combine forces on future talent recruitment incentives providing £400,000 in grants for companies to provide higher apprenticeship training for employees and to host industrial placements.

    January 28, 2014
  • PharmApprove, Leading Regulatory and Scientific Communications Firm, Expands in Europe

    PharmApprove, Leading Regulatory and Scientific Communications Firm, Expands in Europe, Coos De Graaf Named New Head of European Operations

    December 18, 2013
  • Selcia celebrates success of MHRA inspection of GMP Radiolabelling facility

    Selcia celebrates the success of a recent inspection of its GMP Radiolabelling facility by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).

    November 25, 2013
  • New ground-breaking IVF Technology now available at IVF Spain in Alicante

    IVF Spain is offering Early Embryo Viability Assessment (Eeva™) test. Eeva Designed to Improve IVF Outcomes.

    November 1, 2013
  • Renowned UK IVF clinic reflects on success with Eeva™

    Renowned UK IVF clinic reflects on success with Eeva™. Enhanced patient experience a key benefit of new IVF technology.

    November 1, 2013
  • UK’s first home test for hereditary breast cancer

    Women at risk of hereditary breast cancer are being offered a speedy test and expert consultation over the phone in a unique and revolutionary new service.

    October 23, 2013
  • Record Levels of Foreign Direct Investment in London – LBIC News

    The London Bioscience Innovation Centre’s LBIC Newsletter for Autumn 2013 out today examines how London’s position as a global leader in science and technology is leading to record levels of foreign direct investment (FDI).

    October 16, 2013
  • Fujifilm Diosynth Biotechnologies Opens New Manufacturing Facility

    Fujifilm Diosynth Biotechnologies today formally opened its new mammalian cell culture cGMP manufacturing facility at a ceremony performed by HRH The Duke of Gloucester.

    October 2, 2013
  • to-BBB Presents Clinical Data on Lead Product 2B3-101

    to-BBB presents clinical data on lead product 2B3-101, a potential new treatment option for patients with brain cancer an active transport processes at the blood-brain barrier.

    September 26, 2013
  • Cambridge Research Biochemicals acquires rights to novel drug therapy technology

    Cambridge Research Biochemicals acquires rights to novel technology useful for development of gene and drug therapies

    September 10, 2013
←Previous Page
1 … 74 75 76 77 78 … 80
Next Page→

We have all the tools to bring your innovation to life.

    • LinkedIn
    • X
Our Expertise
  • Design
  • Digital Marketing
  • PR & Communications
About Us
  • About Sciad
  • Our Team
  • Careers
Contact Us

hello@sciad.com

+44 (0)20 3405 7892

  • Privacy Policy
  • Terms & Conditions

© 2026 Sciad Communications